R Squared Ltd purchased a new stake in Maximus, Inc. (NYSE:MMS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 720 shares of the health services provider’s stock, valued at approximately $54,000.
Several other large investors have also recently made changes to their positions in MMS. UMB Bank n.a. raised its position in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 158 shares during the period. Petrus Trust Company LTA grew its stake in shares of Maximus by 2.7% in the third quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after buying an additional 185 shares in the last quarter. Holocene Advisors LP raised its holdings in shares of Maximus by 6.5% in the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock valued at $366,000 after buying an additional 239 shares during the period. V Square Quantitative Management LLC acquired a new position in Maximus during the 3rd quarter worth about $25,000. Finally, MML Investors Services LLC boosted its holdings in Maximus by 6.5% during the 3rd quarter. MML Investors Services LLC now owns 4,870 shares of the health services provider’s stock valued at $454,000 after acquiring an additional 299 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Maximus
In related news, CEO Bruce Caswell purchased 3,500 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were bought at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the purchase, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now directly owns 6,567 shares in the company, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 7,063 shares of company stock valued at $502,017 over the last quarter. 1.60% of the stock is owned by insiders.
Maximus Trading Down 0.9 %
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.59%. Maximus’s payout ratio is currently 24.00%.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on MMS shares. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Wednesday. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd.
Get Our Latest Research Report on Maximus
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What does consumer price index measure?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.